Evidence map›Paper›PMID 34704822›Full record

Observational studyBiomarkers in medicine2021

Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19.

Serap Biberoğlu, Afşin İpekci, İbrahim İkizceli, Fatih Çakmak, Yonca S Akdeniz, Altuğ Kanbakan, Dildar Konukoğlu, İbrahim M Bolayırlı, Şermin Börekçi, Seval Ürkmez and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Biomarkers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Serap BiberoğluDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0003-4709-3315
Afşin İpekciDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0001-6125-4061
İbrahim İkizceliDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-9825-4716
Fatih ÇakmakDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-8813-4139
Yonca S AkdenizDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-4843-1155
Altuğ KanbakanDepartment of Emergency Medicine, Yuksekova State Hospital, Hakkari, Turkey.ORCID 0000-0002-1063-3018
Dildar KonukoğluDepartment of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-6095-264X
İbrahim M BolayırlıDepartment of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0001-5755-7860
Şermin BörekçiDepartment of Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-0089-1312
Seval ÜrkmezDepartment of Intensive Care (Anesthesia & Reanimation), Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0002-3412-4226
Seda ÖzkanDepartment of Emergency Medicine, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.ORCID 0000-0003-1835-8820
Istanbul University-Cerrahpaşa · TRSivas State Hospital · TR

Funding

Financial support of the study was provided by the Istanbul University-Cerrahpaşa Rectorate Scientific Research Projects Coordination Unit No: TSG-2020-34917, Date: Provided by 28.05.2020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HypertensionAdultAgedAged, 80 and overAngiotensin-Converting Enzyme 2Angiotensin IIDisease-Free SurvivalFemaleHumansMaleMiddle AgedProspective StudiesSARS-CoV-2Survival RateACE2 protein, humanAngiotensin-Converting Enzyme 2Angiotensin IIACE2ANG IICOVID-19hypertension

Identifiers

PMID34704822
PMCPMC8589000
OpenAlexW3210816394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.